PT81584B - Process for the isolation and detection of discrete mammalian genes associated with tumor metastases - Google Patents

Process for the isolation and detection of discrete mammalian genes associated with tumor metastases

Info

Publication number
PT81584B
PT81584B PT81584A PT8158485A PT81584B PT 81584 B PT81584 B PT 81584B PT 81584 A PT81584 A PT 81584A PT 8158485 A PT8158485 A PT 8158485A PT 81584 B PT81584 B PT 81584B
Authority
PT
Portugal
Prior art keywords
discrete
isolation
detection
genes associated
mammalian genes
Prior art date
Application number
PT81584A
Other languages
English (en)
Portuguese (pt)
Other versions
PT81584A (en
Inventor
Robert A Weinberg
Shelly C Bernstein
Original Assignee
Whitehead Biomedical Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Whitehead Biomedical Inst filed Critical Whitehead Biomedical Inst
Publication of PT81584A publication Critical patent/PT81584A/pt
Publication of PT81584B publication Critical patent/PT81584B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82—Translation products from oncogenes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5014—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
    • G01N33/5017—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity for testing neoplastic activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
PT81584A 1984-11-30 1985-11-29 Process for the isolation and detection of discrete mammalian genes associated with tumor metastases PT81584B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US67662584A 1984-11-30 1984-11-30

Publications (2)

Publication Number Publication Date
PT81584A PT81584A (en) 1985-12-01
PT81584B true PT81584B (en) 1987-04-07

Family

ID=24715276

Family Applications (1)

Application Number Title Priority Date Filing Date
PT81584A PT81584B (en) 1984-11-30 1985-11-29 Process for the isolation and detection of discrete mammalian genes associated with tumor metastases

Country Status (13)

Country Link
EP (1) EP0203970A1 (fi)
JP (1) JPS62501399A (fi)
AU (1) AU5197986A (fi)
DK (1) DK359486A (fi)
ES (1) ES8705043A1 (fi)
FI (1) FI863095A0 (fi)
GR (1) GR852864B (fi)
HU (1) HUT41837A (fi)
IL (1) IL77157A0 (fi)
NO (1) NO863066L (fi)
PT (1) PT81584B (fi)
WO (1) WO1986003226A1 (fi)
ZA (1) ZA859070B (fi)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5049662A (en) * 1987-10-13 1991-09-17 The United States Of America As Represented By The Department Of Health And Human Services Kit for diagnosing cancer metastatic potential
DK0495910T3 (da) 1989-10-18 2002-01-14 Us Health Fremstilling og anvendelse af humant nm23-H2-protein og derimod rettede antistoffer
US6251597B1 (en) 1996-03-29 2001-06-26 Millennium Pharmaceuticals, Inc. Methods for detecting fohy030
US6825320B1 (en) 1995-03-29 2004-11-30 Millenium Pharmaceuticals, Inc. FOHY03 polypeptides
US6794185B1 (en) 1995-03-29 2004-09-21 Millennium Pharmaceuticals, Inc. fohy030 nucleic acid molecules
US5633161A (en) * 1995-03-29 1997-05-27 Millennium Pharmaceuticals, Inc. Murine gene fomy030 coding for tumor progression inhibitor
AU725186B2 (en) * 1995-11-16 2000-10-05 Baylor College Of Medicine Method for identifying metastatic sequences
US5783182A (en) * 1996-01-30 1998-07-21 Baylor College Of Medicine Method for identifying metastatic sequences
USRE38490E1 (en) 1995-11-16 2004-04-06 Baylor College Of Medicine Method for identifying metastatic sequences
WO1997025443A1 (en) * 1996-01-10 1997-07-17 The University Of Liverpool Metastasis inducing dna's
USRE38392E1 (en) 1996-01-30 2004-01-20 Baylor College Of Medicine Method for identifying metastatic sequences
US6312909B1 (en) 1996-03-29 2001-11-06 Millennium Pharmaceuticals, Inc. Compositions and methods for the diagnosis prevention and treatment of tumor progression
CA2308565A1 (en) 1997-11-05 1999-05-14 Baylor College Of Medicine Sequences for targeting metastatic cells
WO1999046385A2 (en) 1998-03-13 1999-09-16 Baylor College Of Medicine Compositions and methods for the treatment and prevention of metastatic disorders
US7462491B2 (en) 2002-01-31 2008-12-09 Baylor College Of Medicine Methods and compositions for diagnosis and monitoring of prostate cancer progression by detection of serum caveolin

Also Published As

Publication number Publication date
AU5197986A (en) 1986-06-18
JPS62501399A (ja) 1987-06-11
DK359486D0 (da) 1986-07-29
FI863095A (fi) 1986-07-29
NO863066L (no) 1986-09-29
WO1986003226A1 (en) 1986-06-05
DK359486A (da) 1986-07-29
ZA859070B (en) 1986-07-30
NO863066D0 (no) 1986-07-29
GR852864B (fi) 1986-03-28
EP0203970A1 (en) 1986-12-10
FI863095A0 (fi) 1986-07-29
PT81584A (en) 1985-12-01
ES549438A0 (es) 1987-04-16
IL77157A0 (en) 1986-04-29
ES8705043A1 (es) 1987-04-16
HUT41837A (en) 1987-05-28

Similar Documents

Publication Publication Date Title
PT82226A (en) Process for the preparation of 3-aryluraciles and pesticeides therewith
GB8311905D0 (en) Isolation and detection of nucleotide sequence
AU590004B2 (en) Multiple zone heating of molds
DE3269023D1 (en) Process for the production of alpha-galactosidase and uses of the enzyme thus obtained
EP0190726A3 (en) Novel deoxyadenosine phosphate compounds and methods of making and using the same
PT81584A (en) Process for the isolation and detection of discrete mammalian genes associated with tumor metastases
JPS57202289A (en) Culturing of uncourage dependent cell
IL62728A (en) Assay for the determination of enzymes and means for carrying out the method
PT80783A (en) Process for the preparation of benzimidazols bezoxazols and benzothiazols
PT82917A (en) Process for the preparation of modified enzymes
ZA844952B (en) Process and reagent for the determination of alpha-amylase
GB2160520B (en) Process for the isolation of vinyl acetate
ZA8410146B (en) Continuous bioreactor and process
PT81835B (en) Process for the preparation of spirodioxolanes spirodithiolanes and spirooxothiolanes
GB2158010B (en) Numbered documents and methods of and means for production thereof
EP0160417A3 (en) Improved fermentation process
IL82930A (en) Antibodies for the detection of mammalian carcinomas and their preparation
EP0208195A3 (en) Process for the preparation of magnetite pigments
ZA828300B (en) Inhibiting the proliferation and migration of tumor cells
EP0200650A3 (en) System and process for measuring the strength of sheet material
EP0207591A3 (en) Glass-ceramic product and method of making the same
PT83137A (en) Process for the preparation of cardiotonic heterocyclocarbonyl- and acetyl-thiazolones
EP0184993A3 (en) Process for the manufacture of azo dye preparations
GB2168705B (en) Novel bacteriolytic enzyme and process for preparing the same
DE3660220D1 (en) Process for the preparation of chloronitroanilines and chloronitrophenols